1 Future studies should focus on addressing the relevance and c
2 Future studies should focus on better defining the role of MA
3 oportion of genetic phenotypes vary in different countries,
future studies should focus on differences in susceptibility
4 Future studies should focus on dissemination and optimizing t
5 Future studies should focus on distinguishing which discharge
6 Future studies should focus on early identification of such c
7 Our results suggest that
future studies should focus on elucidating controls on the pr
8 As our field continues to evolve,
future studies should focus on emerging technologies and ther
9 Future studies should focus on evaluating lifestyle and obesi
10 ase the risk of developing lymphoma, leukemia, and myeloma,
future studies should focus on evaluating other potential con
11 Future studies should focus on examining residency interventi
12 Future studies should focus on gene discovery.
13 Future studies should focus on how treatment and intervention
14 Future studies should focus on identification of causal allel
15 Future studies should focus on identifying methods of patient
16 Future studies should focus on identifying sources of variati
17 Future studies should focus on identifying tumor and patient
18 Future studies should focus on improving the prediction of no
19 Future studies should focus on interactions among and between
20 Future studies should focus on investigating other abnormalit
21 Future studies should focus on issues such as age-related mic
22 Future studies should focus on larger LOAD datasets with long
23 Future studies should focus on long-term neurocognitive effec
24 Future studies should focus on molecular mechanisms underlyin
25 Future studies should focus on optimizing the dose of peginte
26 Future studies should focus on optimum patient selection for
27 Future studies should focus on other commonly consumed subcla
28 Future studies should focus on patients with larger, grade II
29 Future studies should focus on prevention and relief of chemo
30 Future studies should focus on reasons-perhaps compliance or
31 Patients remain at risk for significant morbidity, and
future studies should focus on recognizing predictors of morb
32 Future studies should focus on strategies to identify patient
33 Future studies should focus on the analysis of mortality afte
34 Future studies should focus on the identification of and trea
35 Future studies should focus on the implications for accurate
36 Future studies should focus on the interplay between the coag
37 Future studies should focus on the mechanisms and levels of i
38 Future studies should focus on the possible beneficial effect
39 To assess the value of bariatric surgery,
future studies should focus on the potential benefit of impro
40 h the survival of critically ill patients and suggests that
future studies should focus on the resources of the health ca
41 of TWIST2 in silencing p53 function in other malignancies,
future studies should focus on the role of TWIST2 in CLL and
42 Future studies should focus on the use of radionuclides with
43 Future studies should focus on the utilization of this marker
44 Future studies should focus on understanding and mitigating t
45 Future studies should focus on understanding the determinants
46 Future studies should focus on understanding the different tr
47 Future studies should focus on understanding the mechanisms f
48 ent therapeutically and they are more laborious to prepare,
future studies should focus on unselected young TILs.
49 Future studies should focus on what types of spending are mos
50 Future studies should focus on whether this biomarker is more